trending Market Intelligence /marketintelligence/en/news-insights/trending/yecel6miyzirsf38yx03rw2 content esgSubNav
In This List

The Medicines Co. appoints director

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


The Medicines Co. appoints director

Parsippany, N.J.-based biopharmaceutical company The Medicines Co. appointed Sarah Schlesinger to serve as an independent director, with immediate effect.

Schlesinger is chair of The Rockefeller University Hospital's institutional review board and a senior physician and associate professor of clinical investigation at the university.

She has worked in the field of cellular immunity for more than 20 years.